Overview

Artemether/Lumefantrine and Vivax Malaria

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The cure rate of artemether/lumefantrine in the treatment of vivax malaria.
Phase:
Phase 3
Details
Lead Sponsor:
University of Khartoum
Collaborator:
University of Kassala, Sudan
Treatments:
Artemether
Artemether-lumefantrine combination
Artemether, Lumefantrine Drug Combination
Artemisinins
Lumefantrine